Hemostasis Flashcards
CLOT BUSTERS
activate plasminogen (t-PA, u-PA, streptokinase), break down existing clots, do not work to prevent clots
Argatroban and pradaxa
thrombin inhibitors
Warfarin is reversed by
giving vitamin K
Warfarin is SLOW bc
it only affects factors synthesized after drug administration, pre-existing factors are functional
Warfarin mechanism
inhibits vitamin K dependent gamma-carboxylase (prothrombin, 7, 9, 10) impairs coagulation
Gamma-carboylation of factors
vitamin K dependent, necessary for factors to bind Ca in order for activation
Heparin
activates antithrombin to inhibit thrombin and Facto 10a, DOES NOT destroy existing clots
Heparin-induced thrombocytopenia
<100,000 immune reaction
Heparin can be neutralized with
protamine
Aspirin
inhibits COX-1 and TXA2 production
Platelet receptor inhibitor
GpIIb-IIa inhibit platelet from binding fibrinogen
Fibrinolytic drugs
plasminogen activator drugs, act like tissue plasminogen activators t-PA, u-PA
Presence of FDP and D-dimers
thrombosis
Elevated homocysteine
inhibits thromomodulin, inhibits heparan sulfate activity, inhibits plasminogen and fibrinolysis (long coagulation and clot presence)
Factor 5 Leiden
INCREASED thrombosis risk, resistant to proteolytic Protein Ca, remains active longer
Protein C/S
Destroys 5a and 8a
Protein C/S deficiency
thombrosis risk
aPTT
time required to observe a clot when exposing plasma to negative charged surface - measure heparin activity
Heparin
antithrombin activation (>1000X)
antithrombin
protease inhibitor that irreversibly inhibits thrombin (high MW) and 10a (low MW)
Antithrombin deficiency
thrombosis risk
TFP I (Tissue Factor Pathway inhibitor)
protease inhibitor inhibits 7a and 10a no known deficiencies - fatal>?
Hemophiliac hemarthroses
bleeding into joints
Hemophiliac hematomas
bleeding into subQ CT and muscle